12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Company News  |  Other News

Silence Therapeutics cancer, inflammation news

Silence Therapeutics reduced headcount by about 20 (33%) to 40 as part of the company's...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >